Automated assay of hyaluronic acid in serum

Immuno-Analyse et Biologie Specialisee

Volumn 23, Issue 3, 2008, Pages 148-152

  Guechot J ^a   Edrief, S ^a   Lasnier, E ^a   Kuper R ^b  

^a HÔPITAL SAINT ANTOINE   (France)

^b Wako Pure Chemical Industries   (Germany)

Author keywords

Assay; Automation; Hyaluronic acid; Liver fibrosis

Indexed keywords

HYALURONIC ACID; MARKER; MONOCLONAL ANTIBODY; RECOMBINANT HYALURONIC ACID BINDING PROTEIN; RECOMBINANT PROTEIN;

ACCURACY; ARTICLE; ASSAY; AUTOANALYZER; AUTOMATION; CLINICAL CHEMISTRY; HEPARINIZATION; HUMAN; LATEX AGGLUTINATION TEST; PRIORITY JOURNAL; SENSITIZATION; SERUM;

EID: 43049120598     PISSN: 09232532     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.immbio.2008.02.011     Document Type: Article

References (15)

1. Fraser J.R., Laurent T.C., and Laurent U.B. Hyaluronan: its nature, distribution, functions and turnover. J Intern Med 242 (1997) 27-33
2. Nyberg A., Engström-Laurent A., and Lööf L. Serum hyaluronate in primary biliary cirrhosis. A biochemical marker for progressive liver damage. Hepatology 8 (1988) 142-146
3. Guéchot J., Laudat A., Loria A., Serfaty L., Poupon R., and Giboudeau J. Diagnostic accuracy of hyaluronan and type III procollagen amino-terminal peptide serum assays as markers of liver fibrosis in chronic viral hepatitis C evaluated by ROC curve analysis. Clin Chem 42 (1996) 558-563
4. Wong V.S., Hughes V., Trull A., Wight D.G., Petrik J., and Alexander G.J. Serum hyaluronic acid is a useful marker of liver fibrosis in chronic hepatitis C virus infection. J Viral Hepat 5 (1998) 187-192
5. McHutchison J.G., Blatt L.M., De Medina M., Craig J.R., Conrad A., Schiff E.R., et al. Measurement of serum hyaluronic acid in patients with chronic hepatitis C and its relationship to liver histology. J Gastrol Hepatol 15 (2000) 945-951
6. Poupon R.E., Balkau B., Guéchot J., and Heintzmann F. Predictive factors in ursodeoxycholic acid-treated patients with primary biliary cirrhosis. Role of serum markers of connective tissue. Hepatology 19 (1994) 635-640
7. Guéchot J., Serfaty L., Bonnand A.M., Chazouillères O., Poupon R.E., and Poupon R. Prognostic value of serum hyaluronan in patients with compensated HCV cirrhosis. J Hepatol 32 (2000) 447-452
8. Patel K., Gordon S.C., Jacobson I., Hezode C., Oh E., Smith K.M., et al. Evaluation of a panel of non-invasive serum markers to differentiate mild from moderate-to-advanced liver fibrosis in chronic hepatitis C patients. J Hepatol 41 (2004) 935-942
9. Rosenberg W.M.C., Voelker M., Thiel R., Becka M., Burt A., Schuppan D., et al. Serum markers detect the presence of liver fibrosis: a cohort study. Gastroenterology 127 (2004) 1704-1713
10. Adams L.A., Bulsara M., Rossi E., DeBoer B., Speers D., George J., et al. Hepascore: an accurate validated predictor of liver fibrosis in chronic hepatitis C infection. Clin Chem 51 (2005) 1867-1873
11. Calès P., Oberti F., Michalak S., Hubert-Fouchard I., Rousselet M.C., Konaté A., et al. A novel panel of blood markers to assess the degree of liver fibrosis. Hepatology 42 (2005) 1373-1381
12. Dufour D.R. Assessment of liver fibrosis: Can serum become the sample of choice?. Clin Chem 51 (2005) 1763-1764
13. Massart C., Bendavid C., Gibassier J., Perrin M., Deugnier Y., and Lainé F. Importance of the functional sensitivity determination of a serum hyaluronic acid assay for the prediction of liver fibrosis in patients with features of the metabolic syndrome. Clin Chem Lab Med 44 (2006) 505-507
14. Fujio K, Kanke F, Adachi H, Kobatake S, Satomura S. Development of a hyaluronic acid detection reagent using agglutination method. 2007 AACC annual meeting, July 15-19 2007, San Diego, California.
15. Halfon P., Bourlière M., Pénaranda G., Deydier R., Renou C., Botta-Fridlund D., et al. Accuracy of hyaluronic acid level for predicting liver fibrosis stages in patients with hepatitis C virus. Comp Hepatol 4 (2005) 6